DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,941,000 | -18.9% | 305,125 | 0.0% | 0.66% | -21.8% |
| Q4 2021 | $3,628,000 | -26.8% | 305,125 | 0.0% | 0.84% | -35.7% |
| Q3 2021 | $4,955,000 | -22.8% | 305,125 | 0.0% | 1.31% | -41.6% |
| Q2 2021 | $6,420,000 | -3.9% | 305,125 | -29.1% | 2.24% | -15.9% |
| Q1 2021 | $6,680,000 | – | 430,112 | – | 2.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |